Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to our new ARUK Clinical Research Fellows, Dr Malvika Gulati and Miss Jennifer Lane on their successful Fellowship applications.

Jennifer will be studying the “Epidemiology of common hand conditions”. The project will study trends in disease variation and the surgical management of the condition at a national level using routinely collected UK GP and hospital data. Two large research studies, UK Biobank and the Million Women Study, will also be used to study over 1.8 million people to consider risk factors in developing severe osteoarthritis.

Commenting on the news of her successful application Jennifer stated “I'm thrilled to be working with ARUK for this project that I hope will help us better understand why people develop hand conditions, and aid us in determining the best surgical treatments for the future."

Jennifer will be sponsored by Prof Dominic FurnissProf Daniel Prieto-Alhambra and Prof Jane Green at the Million Women Study based in the Cancer Epidemiology Unit at the Nuffield Department of Population Health.

Dr Malvika Gulati will be looking at ”The role of gender, menopause and sex hormones in painful hand osteoarthritis (OA)”. Hand OA is common, affecting 2 million people in the UK and can cause pain, swelling and deformity and has greater occurrences in women. The project aims to improve understanding of the role of gender and hormonal influences in the pathogenesis of painful hand OA, in order to predict individual outcomes and identify new treatment strategies.

On acceptance of the award Malvika stated "I am grateful for the opportunity that Arthritis Research UK has given us. Hand osteoarthritis is the most common form of arthritis in the hand, yet treatment options are limited. This funding will allow us to better understand the condition and test our hypothesis that hormones may play a role in its development.”  

Malvika will be sponsored by Prof Fiona WattProf Tonia Vincent and Prof Nigel Arden.

FUNDING BODY

New funding for arthritis research

Similar stories

Professor Chris Buckley joins the Kennedy Institute as Director of Clinical Research

Moving to the University of Oxford with the Arthritis Therapy Acceleration Programme (A-TAP) will help accelerate the discovery of new treatments for inflammatory diseases.

Behind enemy lines: research finds a new ally in the fight against cardiovascular disease hidden within the vessel wall itself

A new study reveals the existence of a powerful ally in the fight against cardiovascular disease, a protective subset of vascular macrophages expressing the C-type lectin receptor CLEC4A2, a molecule which fosters "good" macrophage behaviour within the vessel wall.

New Oxford-Zeiss Centre of Excellence opens at the University of Oxford

The Kennedy Institute for Rheumatology and the Institute of Developmental and Regenerative Medicine announce the launch of the Oxford-Zeiss Centre of Excellence, providing state-of-the-art imaging technologies to lead future discoveries in global health and disease.

The Kennedy Institute scoops sustainability award

A new roof extension was awarded the 2021 Green Award for Sustainability by the Oxford Preservation Trust alongside a Certificate in the New Building category.

Fiona Powrie appointed new Deputy Chair of Wellcome’s Board of Governors

Fiona Powrie, Director of the Kennedy Institute of Rheumatology at the University of Oxford has been selected as the next Deputy Chair of Wellcome’s Board of Governors.

A drug being trialled to treat cancer, could be the key to reducing gut inflammation

Published in Nature Communications, a new study reveals a new signalling pathway behind macrophage inflammatory activity